| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.12 |
0.25 |
0.12 － 0.25 |
Quinupristin/Dalfopristin (Synercid)  |
265 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.12 |
0.5 |
0.12 － 1 |
Minocycline (Minocycline hydrochloride, Minocin) |
476 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.12 |
2 |
≤0.03 － >4 |
Gatifloxacin (Tequin) |
412 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.12 |
4 |
0.06 － >4 |
Levofloxacin (Levaquin, Quixin) |
265 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.12 |
12 |
≤0.06 － 0.25 |
Clindamycin (Cleocin) |
265 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.25 |
0.25 |
0.25 － >8 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
265 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.25 |
0.5 |
? － ? |
Quinupristin/Dalfopristin (Synercid) |
39 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.25 |
0.5 |
? － ? |
Tigecycline (GAR-936, Tigacyl) |
39 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.25 |
1 |
0.12 － 1 |
Tigecycline (GAR-936, Tigacyl) |
476 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
>0.25 |
>2 |
0.06 － >2 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
412 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.25 |
2 |
0.12 － 64 |
Doxycycline (Doxycycline hyclate, Doxy, Vibra, Vibramycin) |
476 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
>0.25 |
>2 |
? － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
39 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
>0.25 |
>8 |
? － ? |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
39 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
≤0.5 |
≤0.5 |
≤0.5 － >8 |
Imipenem |
412 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.5 |
1 |
≤0.5 － 1 |
Doxycycline (Doxycycline hyclate, Doxy, Vibra, Vibramycin) |
265 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.5 |
1 |
≤0.5 － 8 |
Zosyn |
412 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.5 |
2 |
≤0.12 － 8 |
Cefepime (Maxipime) |
412 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
>0.5 |
>2 |
≤0.5 － >2 |
Co-trimoxazole (Trimethoprim-sulfamethoxazole, TMP-SMX) |
412 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.5 |
2 |
? － ? |
Doxycycline (Doxycycline hyclate, Doxy, Vibra, Vibramycin) |
39 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
0.5 |
4 |
0.25 － >128 |
Tetracycline (Sumycin, Achromycin V, Steclin) |
476 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
1 |
1 |
0.5 － 1 |
Linezolid (PNU-100766, U-100766, Zyvox) |
265 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
1 |
1 |
? － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
39 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
1 |
2 |
≤0.12 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
412 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
1 |
2 |
0.25 － 2 |
LBM415 (NVP-PDF-713, VIC-10495) |
265 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
1 |
2 |
1 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
265 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
1 |
2 |
? － ? |
Vancomycin (Vancocyn, Lyphocin) |
39 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
1 |
3 |
? － ? |
Cefepime (Maxipime) |
126 |
| Staphylococci (coagulase-negative + oxacillin-susceptible) |
≤2 |
≤2 |
≤2 － ? |
Gentamicin (Gentamycin, Garamycin) |
265 |